Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Aim: The aim of this study was to evaluate the use of Resovist in perfusion-weighted imaging (PWI) of rat hyperacute cerebral infarction.
Material And Methods: 30 Wistar rats were randomly divided into 2 groups. Group A was intravenously injected with 8 μmol Fe/kg body weight of Resovist, whilst Group B was injected with 0.2 mmol/kg body weight of Gd-DTPA. These dosages were chosen to provide comparable maximum signal changes in normally perfused brain. CBV, CBF and MTT parameter profiles were obtained for the core diseased region and the penumbra of brain ischemia and compared between the two groups. These results were then correlated with pathological findings and TTC staining.
Results: In our rat stroke model, signal-time curves were similar between Gd-DTPA and Resovist, both in the core area with severe ischemia and in the penumbra area with moderate ischemia. The CBV, MTT, and TTP values of PWI for ischemic penumbra in Groups A and B showed no statistical disparity.
Conclusion: The efficacy of Resovist in MR PWI is similar to Gd-DTPA in the diagnosis of perfusion reduction in the rat stroke model.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5137/1019-5149.JTN.8258-13.0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reperfusion failure after successful thrombectomy of large vessel occlusion stroke: clinical and imaging evidence.
Front Neurol
August 2025
Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Introduction: Reperfusion failure (RF) describes a condition in which patients suffering a large vessel occlusion (LVO) stroke present insufficient tissue reperfusion and recovery despite optimal mechanical thrombectomy (MT) results. Approximately 50% of patients suffering from LVO are affected. Our current understanding of the underlying pathomechanisms is limited and mostly based on rodent models.
View Article and Find Full Text PDFEnhancing Diagnostic Accuracy by Utilizing Regional Cerebral Blood Flow (rCBF) as a Value-Added Variable to Dynamic Contrast-Enhanced Perfusion-Weighted Imaging for Differentiating Radionecrosis From Recurrent Brain Tumour.
Cureus
July 2025
Department of Biostatistics, Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, IRN.
Purpose To enhance diagnostic accuracy by incorporating relative cerebral blood flow (rCBF) as an additional parameter to dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) variables, thereby enabling the differentiation between radionecrosis and recurrent brain tumours. Materials and methods This study involved 54 patients who had previously undergone treatment for primary cerebral tumours. All participants received radiotherapy and underwent both conventional MRI and DSC-PWI.
View Article and Find Full Text PDFVelocity-Selective arterial spin labeling (VSASL) for cerebral blood volume assessment in gliomas: comparison with VSASL based cerebral blood flow and dynamic susceptibility contrast MRI.
Neuroradiology
September 2025
Department of Radiology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Purpose: Cerebral blood volume (CBV) maps created using dynamic susceptibility contrast-enhanced perfusion weighted imaging (DSC-PWI) are valuable but may be limited by gadolinium contraindications in certain clinical scenarios. A noninvasive perfusion method for CBV assessment based on velocity-selective (VS) ASL has emerged. This study is to evaluate the performance of VSASL-derived CBV among glioma patients in clinical practice, comparing with the VSASL-based cerebral blood flow (CBF) and DSC-PWI.
View Article and Find Full Text PDFAdvanced MRI, Radiomics and Radiogenomics in Unravelling Incidental Glioma Grading and Genetic Status: Where Are We?
Medicina (Kaunas)
August 2025
Neuroradiology Unit, NESMOS (Neuroscience, Mental Health and Sensory Organs) Department, Sant'Andrea Hospital, La Sapienza University, Via di Grottarossa, 1035-1039, 00189 Rome, Italy.
The 2021 WHO classification of brain tumours revolutionised the oncological field by emphasising the role of molecular, genetic and pathogenetic advances in classifying brain tumours. In this context, incidental gliomas have been increasingly identified due to the widespread performance of standard and advanced MRI sequences and represent a diagnostic and therapeutic challenge. The impactful decision to perform a surgical procedure deeply relies on the non-invasive identification of features or parameters that may correlate with brain tumour genetic profile and grading.
View Article and Find Full Text PDFMultiparametric MRI for differential diagnosis of primary central nervous system lymphoma and atypical glioblastoma: an analysis incorporating DWI, DCE-MRI, and contrast agent preload DSC-PWI.
BMC Med Imaging
August 2025
Department of Radiology, The First Affiliated Hospital, Fujian Medical University, 20 Cha-Zhong Road, Fuzhou, Fujian, 350005, P.R. China.
Purpose: The differential diagnosis of primary central nervous system lymphoma (PCNSL) and atypical glioblastoma (aGBM) exhibiting homogeneous enhancement and negligible necrosis poses a significant challenge for conventional MRI. The study aims to investigate diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, and contrast agent (CA) preload dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) to differentiate aGBM and PCNSL.
Materials And Methods: This retrospective study analyzed 27 patients with aGBM (solid enhancement without visible necrosis) and 105 patients with PCNSL, all undergoing preoperative DWI, DCE-MRI, and CA preload DSC-PWI.